BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28416102)

  • 21. Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors.
    Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
    Bioorg Chem; 2016 Oct; 68():23-9. PubMed ID: 27428597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
    Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J
    Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S; Gökçe M; Orhan I; Sahin MF
    Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
    Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
    Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
    Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
    Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
    Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP
    Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mannich-Benzimidazole Derivatives as Antioxidant and Anticholinesterase Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking Study.
    Alpan AS; Sarıkaya G; Çoban G; Parlar S; Armagan G; Alptüzün V
    Arch Pharm (Weinheim); 2017 Jul; 350(7):. PubMed ID: 28379621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
    Alipour M; Khoobi M; Moradi A; Nadri H; Homayouni Moghadam F; Emami S; Hasanpour Z; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Jul; 82():536-44. PubMed ID: 24941128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
    Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
    Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, kinetic studies and molecular modeling of novel tacrine dimers as cholinesterase inhibitors.
    de Aquino RA; Modolo LV; Alves RB; de Fátima Â
    Org Biomol Chem; 2013 Dec; 11(48):8395-409. PubMed ID: 24186541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidation at C-16 enhances butyrylcholinesterase inhibition in lupane triterpenoids.
    Castro MJ; Richmond V; Faraoni MB; Murray AP
    Bioorg Chem; 2018 Sep; 79():301-309. PubMed ID: 29793143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors.
    Ma W; Bi J; Zhao C; Gao Y; Zhang G
    Carbohydr Res; 2020 May; 491():107977. PubMed ID: 32169593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
    Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
    Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study.
    Bak A; Kozik V; Kozakiewicz D; Gajcy K; Strub DJ; Swietlicka A; Stepankova S; Imramovsky A; Polanski J; Smolinski A; Jampilek J
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors.
    Kumar RS; Almansour AI; Arumugam N; Al-Thamili DM; Basiri A; Kotresha D; Manohar TS; Venketesh S; Asad M; Asiri AM
    Bioorg Chem; 2018 Dec; 81():134-143. PubMed ID: 30121001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
    Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.